CTSOVSGTBP• 7 Days (Normalized)
CTSO vs GTBP (Cytosorbents Corporation vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 18 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
-14.61%
Cytosorbents Corporation
Normalized Baseline0.00%
GTBP Performance $7.1
-0.84%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-13.77 pts
GTBP outperforming by 13.77 percentage points
CTSOGTBP
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(3 dates)
| Date | CTSO Price | CTSO Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | -14.61% | $7.10 | -0.84% | -13.77% |
| Sep 21, 2026 | $5.51 | -4.17% | $7.18 | +0.28% | -4.45% |
| Sep 18, 2026 | $5.75 | +0.00% | $7.16 | +0.00% | +0.00% |